The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey.
Alison SkrinarMelita Dvorak-EwellAyla EvinsCarolyn MacicaAgnès LinglartErik Allen ImelChristina Theodore-OklotaJavier San MartinPublished in: Journal of the Endocrine Society (2019)
Despite the common use of oral phosphate and active vitamin D established in the 1980s, children with XLH demonstrate a substantial disease burden, including pain and impaired physical functioning that persists, as demonstrated by similar responses reported in adults with XLH.